INS and hyperlipidemia: The landmark discovery by the Ricci group showed that mice lacking the mitogen-activated protein kinase p38δ displayed improved glucose tolerance due to enhanced insulin secretion from pancreatic β cells and that deletion of p38δ resulted in dramatic activation of PKD and protected against hyperlipidemia-induced insulin resistance and oxidative stress-imposed pancreatic β cell apoptosis [24].